Ovarian Suppression Treatment Is Rare for Premenopausal Women with HR+/HER2+ Breast Cancer
In serious-environment follow, use of ovarian suppression treatment was not common amongst premenopausal individuals with
Breast
Pausing endocrine therapy for pregnancy appears safe for women with breast cancer
December 08, 2022 3 min read Source/Disclosures Published by: Source: Partridge AH, et al. Abstract
Patients With HR+ Breast Cancer May Safely Pause Endocrine Therapy to Pursue Pregnancy
The short-time period recurrence charges ended up similar between people with early-phase hormone receptor–positive breast
The Disparities Women of Color Experience in Breast Cancer Treatment
“Black women are 40 percent more likely to die of a breast cancer diagnosis, period,”
Breast Cancer Gaps Project aims to improve outcomes for Black women
Until the summer time of 2019, when she found a lump on her breast, Adrienne
Woman fighting breast cancer cleared thanks to neoadjuvant chemotherapy
On Valentine’s Day this calendar year, Leticia Davis received the antithesis of a sweetheart of